{"columns": ["cmem_n_edit_distance", "cmem_n_is_updated", "cmem_n_memory_len", "cmem_n_memory_str", "cmem_n_memory_str_len"], "data": [[NaN, NaN, 10.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue. Stages range from Tis (carcinoma in situ) to T4 (advanced tumor).\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information (such as N1a) can be ignored when determining the overall N stage.\nRule 6: The type of cancer (in this case, infiltrative ductal carcinoma) does not affect the staging.\nRule 7: The grade of the cancer (in this case, grade 2) does not affect the staging.\nRule 8: The type of tissue specimen (in this case, tissue specimen matrix: Tissue Specimen Matrix: Tissue Specimen Format: OCT) does not affect the staging.\nRule 9: The type of procurement (in this case, surgery) does not affect the staging.\nRule 10: The treatment details (in this case, treatment: none, treatment details: n/a) do not affect the staging.", 1292.0], [90.0, true, 13.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue. Stages range from Tis (carcinoma in situ) to T4 (advanced tumor).\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information (such as N1a) can be ignored when determining the overall N stage.\nRule 6: The type of cancer (in this case, infiltrative ductal carcinoma) does not affect the staging.\nRule 7: The grade of the cancer (in this case, grade 2) does not affect the staging.\nRule 8: The type of tissue specimen (in this case, tissue specimen matrix: Tissue Specimen Matrix: Tissue Specimen Format: OCT) does not affect the staging.\nRule 9: The type of procurement (in this case, surgery) does not affect the staging.\nRule 10: The treatment details (in this case, treatment: none, treatment details: n/a) do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.", 1579.0], [97.0, true, 14.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue. Stages range from Tis (carcinoma in situ) to T4 (advanced tumor).\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information (such as N1a) can be ignored when determining the overall N stage.\nRule 6: The type of cancer (in this case, infiltrative ductal carcinoma) does not affect the staging.\nRule 7: The grade of the cancer (in this case, grade 2) does not affect the staging.\nRule 8: The type of tissue specimen (in this case, tissue specimen matrix: Tissue Specimen Matrix: Tissue Specimen Format: OCT) does not affect the staging.\nRule 9: The type of procurement (in this case, surgery) does not affect the staging.\nRule 10: The treatment details (in this case, treatment: none, treatment details: n/a) do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.", 1672.0], [94.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue. Stages range from Tis (carcinoma in situ) to T4 (advanced tumor).\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information (such as N1a) can be ignored when determining the overall N stage.\nRule 6: The type of cancer (in this case, infiltrative ductal carcinoma) does not affect the staging.\nRule 7: The grade of the cancer (in this case, grade 2) does not affect the staging.\nRule 8: The type of tissue specimen (in this case, tissue specimen matrix: Tissue Specimen Matrix: Tissue Specimen Format: Frozen) does not affect the staging.\nRule 9: The type of procurement (in this case, surgery) does not affect the staging.\nRule 10: The treatment details (in this case, treatment: none, treatment details: n/a) do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.", 1875.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue. Stages range from Tis (carcinoma in situ) to T4 (advanced tumor).\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information (such as N1a) can be ignored when determining the overall N stage.\nRule 6: The type of cancer (in this case, infiltrative ductal carcinoma) does not affect the staging.\nRule 7: The grade of the cancer (in this case, grade 2) does not affect the staging.\nRule 8: The type of tissue specimen (in this case, tissue specimen matrix: Tissue Specimen Matrix: Tissue Specimen Format: Frozen) does not affect the staging.\nRule 9: The type of procurement (in this case, surgery) does not affect the staging.\nRule 10: The treatment details (in this case, treatment: none, treatment details: n/a) do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.", 1875.0], [80.0, true, 16.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information (such as N1a) can be ignored when determining the overall N stage.\nRule 6: The type of cancer (in this case, infiltrative ductal carcinoma) does not affect the staging.\nRule 7: The grade of the cancer (in this case, grade 2) does not affect the staging.\nRule 8: The type of tissue specimen (in this case, tissue specimen matrix: Tissue Specimen Matrix: Tissue Specimen Format: Frozen) does not affect the staging.\nRule 9: The type of procurement (in this case, surgery) does not affect the staging.\nRule 10: The treatment details (in this case, treatment: none, treatment details: n/a) do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.", 1963.0], [100.0, true, 16.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information (such as N1a) can be ignored when determining the overall N stage.\nRule 6: The type of cancer (in this case, infiltrative ductal carcinoma) does not affect the staging.\nRule 7: The grade of the cancer (in this case, grade 2) does not affect the staging.\nRule 8: The type of tissue specimen (in this case, tissue specimen matrix: Tissue Specimen Matrix: Tissue Specimen Format: OCT) does not affect the staging.\nRule 9: The type of procurement (in this case, surgery) does not affect the staging.\nRule 10: The treatment details (in this case, treatment: none, treatment details: n/a) do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.", 1960.0], [98.0, true, 17.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information (such as N1a) can be ignored when determining the overall N stage.\nRule 6: The type of cancer (in this case, infiltrative ductal carcinoma) does not affect the staging.\nRule 7: The grade of the cancer (in this case, grade 2) does not affect the staging.\nRule 8: The type of tissue specimen (in this case, tissue specimen matrix: Tissue Specimen Matrix: Tissue Specimen Format: OCT) does not affect the staging.\nRule 9: The type of procurement (in this case, surgery) does not affect the staging.\nRule 10: The treatment details (in this case, treatment: none, treatment details: n/a) do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.", 2045.0], [97.0, true, 18.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information (such as N1a) can be ignored when determining the overall N stage.\nRule 6: The type of cancer (in this case, infiltrative ductal carcinoma) does not affect the staging.\nRule 7: The grade of the cancer (in this case, grade 2) does not affect the staging.\nRule 8: The type of tissue specimen (in this case, tissue specimen matrix: Tissue Specimen Matrix: Tissue Specimen Format: OCT) does not affect the staging.\nRule 9: The type of procurement (in this case, surgery) does not affect the staging.\nRule 10: The treatment details (in this case, treatment: none, treatment details: n/a) do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nModified Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.", 2185.0], [97.0, true, 19.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information (such as N1a) can be ignored when determining the overall N stage.\nRule 6: The type of cancer (in this case, infiltrative ductal carcinoma) does not affect the staging.\nRule 7: The grade of the cancer (in this case, grade 2) does not affect the staging.\nRule 8: The type of tissue specimen (in this case, tissue specimen matrix: Tissue Specimen Matrix: Tissue Specimen Format: OCT) does not affect the staging.\nRule 9: The type of procurement (in this case, surgery) does not affect the staging.\nRule 10: The treatment details (in this case, treatment: none, treatment details: n/a) do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nModified Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.", 2339.0], [96.0, true, 20.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information (such as N1a) can be ignored when determining the overall N stage.\nRule 6: The type of cancer (in this case, infiltrative ductal carcinoma) does not affect the staging.\nRule 7: The grade of the cancer (in this case, grade 2) does not affect the staging.\nRule 8: The type of tissue specimen (in this case, tissue specimen matrix: Tissue Specimen Matrix: Tissue Specimen Format: OCT) does not affect the staging.\nRule 9: The type of procurement (in this case, surgery) does not affect the staging.\nRule 10: The treatment details (in this case, treatment: none, treatment details: n/a) do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nModified Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.", 2514.0], [92.0, true, 21.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nModified Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.", 2390.0], [96.0, true, 22.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nModified Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes and N1-N3 indicating increasing levels of cancer in nearby lymph nodes.", 2591.0], [99.0, true, 22.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nModified Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 23: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes and N1-N3 indicating increasing levels of cancer in nearby lymph nodes, regardless of the number of positive lymph nodes.", 2641.0], [66.0, false, 22.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nModified Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 23: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes and N1-N3 indicating increasing levels of cancer in nearby lymph nodes, regardless of the number of positive lymph nodes.", 2641.0], [100.0, true, 22.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nModified Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes and N1-N3 indicating increasing levels of cancer in nearby lymph nodes, regardless of the number of positive lymph nodes.", 2641.0], [100.0, true, 22.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes and N1-N3 indicating increasing levels of cancer in nearby lymph nodes, regardless of the number of positive lymph nodes.", 2636.0], [99.0, true, 23.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes and N1-N3 indicating increasing levels of cancer in nearby lymph nodes, regardless of the number of positive lymph nodes.\nNew Rule 23: The term 'mi' in the N stage indicates micrometastasis.", 2705.0], [98.0, true, 24.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes and N1-N3 indicating increasing levels of cancer in nearby lymph nodes, regardless of the number of positive lymph nodes.\nNew Rule 23: The term 'mi' in the N stage indicates micrometastasis.\nNew Rule 24: The absence of cancer in nearby lymph nodes in the macroscopic description indicates an N0 stage.", 2816.0], [40.0, false, 24.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes and N1-N3 indicating increasing levels of cancer in nearby lymph nodes, regardless of the number of positive lymph nodes.\nNew Rule 23: The term 'mi' in the N stage indicates micrometastasis.\nNew Rule 24: The absence of cancer in nearby lymph nodes in the macroscopic description indicates an N0 stage.", 2816.0], [96.0, true, 25.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes and N1-N3 indicating increasing levels of cancer in nearby lymph nodes, regardless of the number of positive lymph nodes.\nNew Rule 23: The term 'mi' in the N stage indicates micrometastasis.\nNew Rule 24: The absence of cancer in nearby lymph nodes in the macroscopic description indicates an N0 stage.\nNew Rule 25: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes.", 3057.0], [98.0, true, 25.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes, regardless of the number of positive lymph nodes.\nNew Rule 23: The term 'mi' in the N stage indicates micrometastasis.\nNew Rule 24: The absence of cancer in nearby lymph nodes in the macroscopic description indicates an N0 stage.\nNew Rule 25: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes.", 3097.0], [100.0, true, 25.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes, regardless of the number of positive lymph nodes.\nNew Rule 23: The term 'mi' in the N stage indicates micrometastasis.\nNew Rule 24: The absence of cancer in nearby lymph nodes in the macroscopic description indicates an N0 stage.\nNew Rule 25: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes.", 3097.0], [100.0, true, 25.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes, regardless of the number of positive lymph nodes.\nNew Rule 23: The term 'mi' in the N stage indicates micrometastasis.\nNew Rule 24: The absence of cancer in nearby lymph nodes in the macroscopic description indicates an N0 stage.\nNew Rule 25: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes.", 3097.0], [99.0, true, 25.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes, regardless of the number of positive lymph nodes.\nNew Rule 23: The term 'mi' in the N stage indicates micrometastasis.\nNew Rule 24: The absence of cancer in nearby lymph nodes in the macroscopic description indicates an N0 stage.\nNew Rule 25: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage.", 3176.0], [99.0, true, 25.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage.\nNew Rule 23: The term 'mi' in the N stage indicates micrometastasis.\nNew Rule 24: The absence of cancer in nearby lymph nodes in the macroscopic description indicates an N0 stage.\nNew Rule 25: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage.", 3205.0], [99.0, true, 25.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage.\nNew Rule 23: The term 'mi' in the N stage indicates micrometastasis.\nNew Rule 24: The absence of cancer in nearby lymph nodes in the macroscopic description indicates an N0 stage.\nNew Rule 25: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage. The 'a' suffix is used to indicate the presence of micrometastasis.", 3273.0], [100.0, true, 25.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage.\nNew Rule 23: The term 'mi' in the N stage indicates micrometastasis.\nNew Rule 24: The absence of cancer in nearby lymph nodes in the macroscopic description indicates an N0 stage.\nNew Rule 25: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage. The 'a' suffix is used to indicate the presence of micrometastasis.", 3273.0], [99.0, true, 25.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage. The 'a' suffix is used to indicate the presence of micrometastasis.\nNew Rule 23: The term 'mi' in the N stage indicates micrometastasis.\nNew Rule 24: The absence of cancer in nearby lymph nodes in the macroscopic description indicates an N0 stage.\nNew Rule 25: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage. The 'a' suffix is used to indicate the presence of micrometastasis.", 3341.0], [100.0, true, 25.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 17: If all examined lymph nodes are negative for metastases, the N stage is N0.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage. The 'a' suffix is used to indicate the presence of micrometastasis.\nNew Rule 23: The term 'mi' in the N stage indicates micrometastasis.\nNew Rule 24: The absence of cancer in nearby lymph nodes in the macroscopic description indicates an N0 stage.\nNew Rule 25: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage. The 'a' suffix is used to indicate the presence of micrometastasis.", 3341.0], [99.0, true, 24.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage. The 'a' suffix is used to indicate the presence of micrometastasis.\nNew Rule 23: The term 'mi' in the N stage indicates micrometastasis.\nNew Rule 24: The absence of cancer in nearby lymph nodes in the macroscopic description indicates an N0 stage.\nNew Rule 25: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage. The 'a' suffix is used to indicate the presence of micrometastasis.", 3256.0], [100.0, true, 24.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage. The 'a' suffix is used to indicate the presence of micrometastasis.\nNew Rule 23: The term 'mi' in the N stage indicates micrometastasis.\nNew Rule 24: The absence of cancer in nearby lymph nodes in the macroscopic description indicates an N0 stage.\nNew Rule 25: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage. The 'a' suffix is used to indicate the presence of micrometastasis.", 3256.0], [76.0, false, 24.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage. The 'a' suffix is used to indicate the presence of micrometastasis.\nNew Rule 23: The term 'mi' in the N stage indicates micrometastasis.\nNew Rule 24: The absence of cancer in nearby lymph nodes in the macroscopic description indicates an N0 stage.\nNew Rule 25: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage. The 'a' suffix is used to indicate the presence of micrometastasis.", 3256.0], [90.0, true, 21.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nNew Rule 18: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nNew Rule 19: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 20: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 21: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 22: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage. The 'a' suffix is used to indicate the presence of micrometastasis.", 2692.0], [84.0, true, 21.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nNew Rule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nNew Rule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 19: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 20: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 21: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The number of positive lymph nodes is not relevant to determining the N stage. The 'a' suffix is used to indicate the presence of micrometastasis.", 2692.0], [96.0, true, 21.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nNew Rule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nNew Rule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 19: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 20: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 21: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The 'a' suffix is used to indicate the presence of micrometastasis.", 2613.0], [100.0, true, 21.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nNew Rule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nNew Rule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 19: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 20: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 21: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The 'a' suffix is used to indicate the presence of micrometastasis.", 2613.0], [100.0, true, 21.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nNew Rule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nNew Rule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 19: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 20: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 21: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The 'a' suffix is used to indicate the presence of micrometastasis.", 2613.0], [100.0, true, 21.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nNew Rule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nNew Rule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 19: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 20: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 21: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The 'a' suffix is used to indicate the presence of micrometastasis.", 2613.0], [100.0, true, 21.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nNew Rule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nNew Rule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 19: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 20: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 21: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The 'a' suffix is used to indicate the presence of micrometastasis.", 2613.0], [100.0, true, 21.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nNew Rule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nNew Rule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 19: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 20: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 21: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The 'a' suffix is used to indicate the presence of micrometastasis.", 2613.0], [100.0, true, 21.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nNew Rule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nNew Rule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 19: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 20: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 21: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The 'a' suffix is used to indicate the presence of micrometastasis.", 2613.0], [100.0, true, 21.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The number of lymph nodes examined and the number of positive lymph nodes are relevant to determining the N stage.\nRule 14: The presence of extranodal extension in positive lymph nodes increases the N stage.\nRule 15: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 16: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nNew Rule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nNew Rule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nNew Rule 19: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nNew Rule 20: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nNew Rule 21: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes. The 'a' suffix is used to indicate the presence of micrometastasis.", 2613.0], [81.0, true, 20.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes.\nRule 14: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 15: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 16: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nRule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 19: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nRule 20: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.", 2479.0], [96.0, true, 21.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The N stage is determined by the number of negative lymph nodes, with N0 indicating no cancer in nearby lymph nodes, N1 indicating 1-3 negative lymph nodes, and N2 or N3 indicating higher levels of cancer in nearby lymph nodes.\nRule 14: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 15: The number of lymph nodes that are negative for metastases is used to determine the N stage, with N0 indicating no cancer in nearby lymph nodes.\nRule 16: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nRule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 19: The number of lymph nodes that are positive for metastases is not used to determine the N stage, only the number of lymph nodes that are negative for metastases.\nRule 20: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nRule 21: The N stage is determined by the number of positive lymph nodes, with N1 indicating 1-3 positive lymph nodes, N2 indicating 4-9 positive lymph nodes, and N3 indicating 10 or more positive lymph nodes.", 2689.0], [93.0, true, 21.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The N stage is determined by the number of positive lymph nodes, with N1 indicating 1-3 positive lymph nodes, N2 indicating 4-9 positive lymph nodes, and N3 indicating 10 or more positive lymph nodes.\nRule 14: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 15: The number of lymph nodes that are negative for metastases is not used to determine the N stage.\nRule 16: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 19: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 20: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nRule 21: The N stage can be determined by the number of positive lymph nodes, with N1 indicating 1-3 positive lymph nodes, N2 indicating 4-9 positive lymph nodes, and N3 indicating 10 or more positive lymph nodes.", 2480.0], [98.0, true, 21.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The N stage is determined by the number of positive lymph nodes, with N1 indicating 1-3 positive lymph nodes.\nRule 14: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 15: The number of lymph nodes that are negative for metastases is not used to determine the N stage.\nRule 16: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 19: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 20: If the report includes the term 'pN', it indicates that the N stage is based on pathologic examination of lymph nodes.\nRule 21: The N stage can be determined by the number of positive lymph nodes, with N1 indicating 1-3 positive lymph nodes, N2 indicating 4-9 positive lymph nodes, and N3 indicating 10 or more positive lymph nodes.", 2389.0], [92.0, true, 19.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The N stage is determined by the number of positive lymph nodes, with N1 indicating 1-3 positive lymph nodes.\nRule 14: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 15: The number of lymph nodes that are negative for metastases is not used to determine the N stage.\nRule 16: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 19: The number of lymph nodes that are positive for metastases is used to determine the N stage.", 2047.0], [49.0, false, 19.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The N stage is determined by the number of positive lymph nodes, with N1 indicating 1-3 positive lymph nodes.\nRule 14: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 15: The number of lymph nodes that are negative for metastases is not used to determine the N stage.\nRule 16: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 19: The number of lymph nodes that are positive for metastases is used to determine the N stage.", 2047.0], [49.0, false, 19.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The N stage is determined by the number of positive lymph nodes, with N1 indicating 1-3 positive lymph nodes.\nRule 14: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 15: The number of lymph nodes that are negative for metastases is not used to determine the N stage.\nRule 16: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 19: The number of lymph nodes that are positive for metastases is used to determine the N stage.", 2047.0], [100.0, true, 19.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The N stage is determined by the number of positive lymph nodes, with N1 indicating 1-3 positive lymph nodes.\nRule 14: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 15: The number of lymph nodes that are negative for metastases is not used to determine the N stage.\nRule 16: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 19: The number of lymph nodes that are positive for metastases is used to determine the N stage.", 2047.0], [100.0, true, 19.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 13: The N stage is determined by the number of positive lymph nodes, with N1 indicating 1-3 positive lymph nodes.\nRule 14: The pathologic stage is determined by the highest T, N, and M categories, and can be represented as a single Roman numeral (I, II, III, or IV) followed by a letter (A, B, or C) if necessary.\nRule 15: The number of lymph nodes that are negative for metastases is not used to determine the N stage.\nRule 16: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 17: The N stage can be determined from the macroscopic description, even if it is not explicitly stated as N0, N1, N2, or N3.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 19: The number of lymph nodes that are positive for metastases is used to determine the N stage.", 2047.0], [84.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 19: The number of lymph nodes that are positive for metastases is used to determine the N stage.", 1491.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 19: The number of lymph nodes that are positive for metastases is used to determine the N stage.", 1491.0], [94.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 20: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1505.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 20: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1505.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 20: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1505.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 20: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1505.0], [48.0, false, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 20: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1505.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 20: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1505.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The number of lymph nodes that are positive for metastases is used to determine the N stage.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 20: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1505.0], [94.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 20: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1519.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 20: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1519.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 20: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1519.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 20: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1519.0], [90.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 21: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories, even if the M stage is not explicitly stated in the report.", 1617.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 21: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories, even if the M stage is not explicitly stated in the report.", 1617.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 21: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories, even if the M stage is not explicitly stated in the report.", 1617.0], [34.0, false, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 21: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories, even if the M stage is not explicitly stated in the report.", 1617.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 21: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories, even if the M stage is not explicitly stated in the report.", 1617.0], [92.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 18: If the M stage is not specified, it does not affect the overall stage, and the pathologic stage is determined by the highest T and N categories.\nRule 21: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases, even if the M stage is not explicitly stated in the report.", 1579.0], [87.0, true, 13.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging (overridden by Rule 16 in this case).\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1286.0], [78.0, false, 13.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging (overridden by Rule 16 in this case).\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1286.0], [100.0, true, 13.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging (overridden by Rule 16 in this case).\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1286.0], [100.0, true, 13.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging (overridden by Rule 16 in this case).\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1286.0], [100.0, true, 13.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging (overridden by Rule 16 in this case).\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1286.0], [100.0, true, 13.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging (overridden by Rule 16 in this case).\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1286.0], [100.0, true, 13.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The presence or absence of extranodal extension does not affect the staging (overridden by Rule 16 in this case).\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1286.0], [95.0, true, 12.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1163.0], [100.0, true, 12.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1163.0], [100.0, true, 12.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1163.0], [100.0, true, 12.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1163.0], [100.0, true, 12.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1163.0], [100.0, true, 12.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1163.0], [97.0, true, 13.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 17: If no cancer is found in nearby lymph nodes, the N stage is N0.", 1236.0], [97.0, true, 12.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 16: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.", 1163.0], [96.0, true, 13.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 13: The N stage is not affected by the presence or absence of cancer in other lymph nodes or organs.", 1269.0], [100.0, true, 13.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 13: The N stage is not affected by the presence or absence of cancer in other lymph nodes or organs.", 1269.0], [96.0, true, 14.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 13: The N stage is not affected by the presence or absence of cancer in other lymph nodes or organs.\nRule 14: The N stage is not affected by the size of the metastases in the positive lymph nodes.", 1365.0], [95.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 13: The N stage is not affected by the presence or absence of cancer in other lymph nodes or organs.\nRule 14: The N stage is not affected by the size of the metastases in the positive lymph nodes.\nRule 15: The N stage is determined by the total number of positive lymph nodes, regardless of the location (sentinel or non-sentinel)", 1499.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 13: The N stage is not affected by the presence or absence of cancer in other lymph nodes or organs.\nRule 14: The N stage is not affected by the size of the metastases in the positive lymph nodes.\nRule 15: The N stage is determined by the total number of positive lymph nodes, regardless of the location (sentinel or non-sentinel)", 1499.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 13: The N stage is not affected by the presence or absence of cancer in other lymph nodes or organs.\nRule 14: The N stage is not affected by the size of the metastases in the positive lymph nodes.\nRule 15: The N stage is determined by the total number of positive lymph nodes, regardless of the location (sentinel or non-sentinel)", 1499.0], [28.0, false, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 13: The N stage is not affected by the presence or absence of cancer in other lymph nodes or organs.\nRule 14: The N stage is not affected by the size of the metastases in the positive lymph nodes.\nRule 15: The N stage is determined by the total number of positive lymph nodes, regardless of the location (sentinel or non-sentinel)", 1499.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 13: The N stage is not affected by the presence or absence of cancer in other lymph nodes or organs.\nRule 14: The N stage is not affected by the size of the metastases in the positive lymph nodes.\nRule 15: The N stage is determined by the total number of positive lymph nodes, regardless of the location (sentinel or non-sentinel)", 1499.0], [44.0, false, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 13: The N stage is not affected by the presence or absence of cancer in other lymph nodes or organs.\nRule 14: The N stage is not affected by the size of the metastases in the positive lymph nodes.\nRule 15: The N stage is determined by the total number of positive lymph nodes, regardless of the location (sentinel or non-sentinel)", 1499.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 13: The N stage is not affected by the presence or absence of cancer in other lymph nodes or organs.\nRule 14: The N stage is not affected by the size of the metastases in the positive lymph nodes.\nRule 15: The N stage is determined by the total number of positive lymph nodes, regardless of the location (sentinel or non-sentinel)", 1499.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 13: The N stage is not affected by the presence or absence of cancer in other lymph nodes or organs.\nRule 14: The N stage is not affected by the size of the metastases in the positive lymph nodes.\nRule 15: The N stage is determined by the total number of positive lymph nodes, regardless of the location (sentinel or non-sentinel)", 1499.0], [100.0, true, 15.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 13: The N stage is not affected by the presence or absence of cancer in other lymph nodes or organs.\nRule 14: The N stage is not affected by the size of the metastases in the positive lymph nodes.\nRule 15: The N stage is determined by the total number of positive lymph nodes, regardless of the location (sentinel or non-sentinel)", 1499.0], [96.0, true, 16.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 13: The N stage is not affected by the presence or absence of cancer in other lymph nodes or organs.\nRule 14: The N stage is not affected by the size of the metastases in the positive lymph nodes.\nRule 15: The N stage is determined by the total number of positive lymph nodes, regardless of the location (sentinel or non-sentinel)\nRule 16: The N stage is determined by the number of examined lymph nodes and the number of positive lymph nodes", 1611.0], [97.0, true, 17.0, "Rule 1: The T stage is determined by the size of the primary tumor and whether it has invaded nearby tissue.\nRule 2: The N stage is determined by the presence and extent of cancer in nearby lymph nodes. Stages range from N0 (no cancer in nearby lymph nodes) to N3 (extensive cancer in nearby lymph nodes or cancer in distant lymph nodes).\nRule 3: The M stage is determined by the presence or absence of distant metastasis. Stages range from M0 (no distant metastasis) to M1 (distant metastasis present).\nRule 4: The pathologic stage is determined by the highest T, N, and M categories.\nRule 5: Substaging information can be ignored when determining the overall N stage.\nRule 6: The type of cancer does not affect the staging.\nRule 7: The grade of the cancer does not affect the staging.\nRule 8: The type of tissue specimen does not affect the staging.\nRule 9: The type of procurement does not affect the staging.\nRule 10: The treatment details do not affect the staging.\nRule 11: The absence of angiolymphatic invasion does not affect the staging.\nRule 12: The N stage is determined by the number of positive lymph nodes, regardless of the size of the metastases.\nRule 13: The N stage is not affected by the presence or absence of cancer in other lymph nodes or organs.\nRule 14: The N stage is not affected by the size of the metastases in the positive lymph nodes.\nRule 15: The N stage is determined by the total number of positive lymph nodes, regardless of the location (sentinel or non-sentinel)\nRule 16: The N stage is determined by the number of examined lymph nodes and the number of positive lymph nodes\nRule 17: If no positive lymph nodes are found in the examined nodes, the N stage is N0", 1698.0]]}